Jules Bordet Institute

This trial is testing whether adding two drugs, regorafenib and nivolumab, to standard short-course radiation can better shrink rectal tumors before surgery. The goal is to see if this combination leads to a complete disappearance of the tumor, potentially allowing some patients …

This study aims to learn if tracking cancer DNA in the blood can predict how well standard chemotherapy works for people with advanced colorectal cancer that has stopped responding to prior treatments. It observes 103 patients receiving their doctor's chosen standard therapy, col…